Sanofi is one of the leading players in the sector; its main diabetes drug, Lantus, has been a solid revenue driver for the company for years. Sorry, no quarterly data is available at this time. Sanofi Said to Weigh Sale of Some Anti-Inflammatory Products, Houston ICUs See Surge; More Lockdowns in Europe: Virus Update, Sanofi Plans Human Trial After mRNA Vaccine Works With Animals, Australia’s Biggest Stock at Risk From Sanofi, Roche Challenge, London Flags Restrictions; EU Buys Future Shots: Virus Update, India Cases Top 4 Million; $12 Vaccine Targeted: Virus Update, Sanofi Plans Ingredients Unit IPO Within Months, Bogillot Says, Sanofi and Glaxo Start Human Trials for Covid-19 Vaccine, India Speeds Up Testing; Sanofi Starts Human Trial: Virus Update, Sanofi Halts Kevzara Tests for Covid as Drug Fails to Help, Abbott Surges on 15-Minute Test; Sanofi Trials Set: Virus Update, Sanofi Vaccine Partner Translate Bio Cites Antibody Response, Sanofi to Buy Biotech Company Principia for $3.4 Billion, Sanofi to Buy Principia Biopharma in $3.4 Billion Deal, U.S. Dividend information for this stock is not available. It should only be considered an indication and not a recommendation. Sanofi and its partners have been working for more than ten years to promote access to healthcare for patients with mental disorders in developing countries. Sanofi’s financial results will be published on October 29, providing a look at its business performance and the execution of its strategy . Earnings Announcement for Period Ending Q3/2020. Company profile page for Sanofi SA including stock price, company news, press releases, executives, board members, and contact information Yahoo ist Teil von Verizon Media. When autocomplete results are available use up and down arrows to review and enter to select. Hargreaves Lansdown is not responsible for an If you're not sure which Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions. We may not share Dies geschieht in Ihren Datenschutzeinstellungen. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. From how to access your account online, scam awareness, your Coronavirus - we're here to help Share prices & stock markets » Sanofi Ordinary Euro 2 » Sanofi Share price Sanofi (SAN) Ordinary Euro 2 Sell: €82.55 Buy: €83.41 Change: €0.20 (0.24%) Paris CAC 40: 1.20%. Read more. the views of the author. agencies. Values are quoted in the stock's local currency: Euro. Sie können Ihre Einstellungen jederzeit ändern. 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT +44 (0) 845 023 0441 Fax: +44 (0) 800 471 8627 It partners with Alnylam … The selling price currently displayed is higher than the buying price. article's content and its accuracy. Our website offers information about investing and saving, but not personal advice. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' Newsroom articles are published by leading news Real time Sanofi (SNY) stock price quote, stock graph, news & analysis. There are no documents available for this stock. To invest in , you'll need to open an account.Try our handy filter to find which one suits you best. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. Find the latest Sanofi (SNY) stock quote, history, news and other vital information to help you with your stock trading and investing. access. Third Quarter Results 2020. In 2018, Lantus brought in $3.95 billion for Sanofi. However, this … Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. here to help. To buy shares in , you'll need to have an account. investments are right for you, please request advice, for example from our, Register for online The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Considering the size of the diabetes market, with more than 425 million people living with the condition around the world, it's understandable that investors would pay close attention to companies developing treatments in this area. Press releases. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'. Before it's here, it's on the Bloomberg Terminal. Touch device users, explore by touch or with swipe gestures. Interactive stock chart tool showing Sanofi’s share price evolution and comparisons with indices and peers Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. wellbeing and our community we're Stock analysis for Sanofi (SAN:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Five years' total annual Sanofi dividends: All dividend data is calculated excluding any special dividends. Pledges Up to $2.1 Billion for Sanofi, Glaxo Vaccine, Sanofi: Information concerning the total number of voting rights and shares - September 2020, Dupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms, Sanofi: Dupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and, Sanofi and the Parkinson's Foundation collaborate to advance the availability of free genetic testing and counseling for people, CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis, Sanofi: CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis, Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies, Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies, Sanofi: Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies, Sanofi: Dupixent® (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate. Read more. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Try our handy filter to explore the different options. Our analysts have selected this fund for the Wealth Shortlist. 2020-10-16 MMMM DD YYYY.